469 related articles for article (PubMed ID: 33426683)
1. Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients.
Rahman MM; Hasan M; Ahmed A
Rev Med Virol; 2021 Sep; 31(5):1-12. PubMed ID: 33426683
[TBL] [Abstract][Full Text] [Related]
2. The collectrin-like part of the SARS-CoV-1 and -2 receptor ACE2 is shed by the metalloproteinases ADAM10 and ADAM17.
Niehues RV; Wozniak J; Wiersch F; Lilienthal E; Tacken N; Schumertl T; Garbers C; Ludwig A; Düsterhöft S
FASEB J; 2022 Mar; 36(3):e22234. PubMed ID: 35199397
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases.
Sharma RK; Li J; Krishnan S; Richards EM; Raizada MK; Mohandas R
Clin Sci (Lond); 2021 Jan; 135(1):1-17. PubMed ID: 33399851
[TBL] [Abstract][Full Text] [Related]
4. A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice.
Wang Y; Takeshita H; Yamamoto K; Huang Y; Wang C; Nakajima T; Nozato Y; Fujimoto T; Yokoyama S; Hongyo K; Nakagami F; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Rakugi H
FASEB J; 2021 Mar; 35(3):e21419. PubMed ID: 33566370
[TBL] [Abstract][Full Text] [Related]
5. Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression.
Zlacká J; Stebelová K; Zeman M; Herichová I
Physiol Res; 2021 Dec; 70(S2):S177-S194. PubMed ID: 34913351
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID-19 disease.
Khoury EE; Knaney Y; Fokra A; Kinaneh S; Azzam Z; Heyman SN; Abassi Z
J Cell Mol Med; 2021 Apr; 25(8):3840-3855. PubMed ID: 33660945
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries.
Wang K; Gheblawi M; Nikhanj A; Munan M; MacIntyre E; O'Neil C; Poglitsch M; Colombo D; Del Nonno F; Kassiri Z; Sligl W; Oudit GY
Hypertension; 2022 Feb; 79(2):365-378. PubMed ID: 34844421
[TBL] [Abstract][Full Text] [Related]
8. Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.
Osman IO; Melenotte C; Brouqui P; Million M; Lagier JC; Parola P; Stein A; La Scola B; Meddeb L; Mege JL; Raoult D; Devaux CA
Front Immunol; 2021; 12():625732. PubMed ID: 34194422
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of angiotensin converting enzyme 2 (ACE2), angiotensin II (Ang II), miR-141-3p, and miR-421 levels in SARS-CoV-2 patients: a case-control study.
Kakavandi E; Sadeghi K; Shayestehpour M; Mirhendi H; Rahimi Foroushani A; Mokhtari-Azad T; Shafiei Jandaghi NZ; Yavarian J
BMC Infect Dis; 2024 Apr; 24(1):429. PubMed ID: 38649818
[TBL] [Abstract][Full Text] [Related]
10. ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19.
Yamamoto K; Takeshita H; Rakugi H
Clin Sci (Lond); 2020 Nov; 134(22):3047-3062. PubMed ID: 33231620
[TBL] [Abstract][Full Text] [Related]
11. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.
Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110
[TBL] [Abstract][Full Text] [Related]
12. Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection.
Feng F; Chen J; Zhao J; Li Y; Li M; Sun C
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835049
[TBL] [Abstract][Full Text] [Related]
13. ACE2 Shedding and the Role in COVID-19.
Wang J; Zhao H; An Y
Front Cell Infect Microbiol; 2021; 11():789180. PubMed ID: 35096642
[TBL] [Abstract][Full Text] [Related]
14. Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19.
García-Escobar A; Vera-Vera S; Jurado-Román A; Jiménez-Valero S; Galeote G; Moreno R
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053224
[TBL] [Abstract][Full Text] [Related]
15. ADAM-17 Activity and Its Relation to ACE2: Implications for Severe COVID-19.
Sun J; Edsfeldt A; Svensson J; Ruge T; Goncalves I; Swärd P
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892098
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin I and II Stimulate Cell Invasion of SARS-CoV-2: Potential Mechanism via Inhibition of ACE2 Arm of RAS.
Zorad S; Skrabanova M; Zilkova M; Cente M; Turic Csokova N; Kovacech B; Cizkova D; Filipcik P
Physiol Res; 2024 Mar; 73(1):27-35. PubMed ID: 38466002
[TBL] [Abstract][Full Text] [Related]
17. ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease.
Kuriakose J; Montezano AC; Touyz RM
Clin Sci (Lond); 2021 Jan; 135(2):387-407. PubMed ID: 33511992
[TBL] [Abstract][Full Text] [Related]
18. Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers.
Lundström A; Ziegler L; Havervall S; Rudberg AS; von Meijenfeldt F; Lisman T; Mackman N; Sandén P; Thålin C
J Med Virol; 2021 Oct; 93(10):5908-5916. PubMed ID: 34138483
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45
Ratajczak MZ; Bujko K; Ciechanowicz A; Sielatycka K; Cymer M; Marlicz W; Kucia M
Stem Cell Rev Rep; 2021 Feb; 17(1):266-277. PubMed ID: 32691370
[TBL] [Abstract][Full Text] [Related]
20. Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19.
Pedrosa MA; Valenzuela R; Garrido-Gil P; Labandeira CM; Navarro G; Franco R; Labandeira-Garcia JL; Rodriguez-Perez AI
Clin Sci (Lond); 2021 Feb; 135(3):465-481. PubMed ID: 33479758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
